A new study confirms that the use of estrogen plus progesterone increases the risk of both ductal and lobular breast cancer far more than estrogen only; suggests a two-year “safe” period for the use of estrogen and progesterone; and finds that the increased risk for ductal cancers observed in long-term past users of hormone replacement therapy drops off substantially two years after hormone use is stopped.